CANCER CHEMOTHERAPY AND PHARMACOLOGY
期刊基本信息
期刊名称:CANCER CHEMOTHERAPY AND PHARMACOLOGY
出版国家或地区:UNITED STATES
是否OA:No
期刊ISSN:0344-5704
期刊官方网站:http://link.springer.com/journal/280
期刊投稿网址:https://mc.manuscriptcentral.com/ccp
通讯方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
涉及的研究方向:医学-药学
出版周期:Monthly
出版年份:1978
期刊数据表:
最新中科院JCR分区
|
大类(学科)
小类(学科)
JCR学科排名
医学
ONCOLOGY(肿瘤学) 4区
PHARMACOLOGY & PHARMACY(药理学和药剂学) 3区
133/223
107/261
|
|||||||
最新的影响因子
|
2.967 | |||||||
最新公布的期刊年发文量 |
|
|||||||
总被引频次 | 9609 | |||||||
特征因子 | 0.012910 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY英文简介:
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.
CANCER CHEMOTHERAPY AND PHARMACOLOGY中文简介:
癌症化疗和药理学在实验和临床水平上解决了广泛的药理学和肿瘤学问题。这一快速出版媒体的主要重点是新的抗癌药物,他们的实验筛选,临床前毒理学和药理学,单一和联合用药模式,临床一期,二期和三期试验。该杂志发表了以下领域的研究成果:临床毒理学、药物动力学、药效学、药物相互作用和癌症治疗策略中的化疗适应症。癌症化疗和药理学是药理学家和肿瘤学家的基本读物。
历年影响因子
CANCER CHEMOTHERAPY AND PHARMACOLOGY在线问答:
SCI之家专业从事SCI期刊、SSCI期刊、EI源刊、SCOPUS期刊、论文咨询服务。SCI之家有来自美国、新加坡、马来西亚的专业英文母语化编审指导团队为您提供专业的英文论文母语润色服务。专注国际学术咨询服务,我们是认真的!